Skip to main content

IntegraDose Compounding Services LLC

6 ongoing recalls and 2 historical records

Based on the official records currently available to Public Health Trace, 6 recalls naming IntegraDose Compounding Services LLC are currently shown as ongoing. The other 2 records below are historical.

Public Health Trace has 8 recalls naming IntegraDose Compounding Services LLC as the recalling firm, republished from official FDA and USDA sources.

Recall records - 8 total

Recalls by year

A bar chart of the number of recalls naming this company by year.

Recalls by year
YearRecalls
20212
20243
20251
20262
Download CSV

FDA Recall Ongoing2026 recordClass II

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.

by IntegraDose Compounding Services LLC

Reason
Subpotent Drug
Published
June 24, 2026
Distribution
Nationwide

View recall →

FDA Recall Ongoing2026 recordClass II

fentaNYL Citrate, Sterile CADD for Injection, 2,2500 mcg/50mL in Sterile Water, IntegraDose Compounding Services LLC, 3650 Victorie St N, Suite 900, Shoreview, MN, NDC 71139-6030-1.

by IntegraDose Compounding Services LLC

Reason
Subpotent Drug
Published
May 27, 2026
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass I

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

by IntegraDose Compounding Services LLC

Reason
Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.
Published
October 22, 2025
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

fentaNYL Citrate 2,500 mcg/50mL in Sterile Water, 50 mL CADD for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-6030-1

by IntegraDose Compounding Services LLC

Reason
Lack of Assurance of Sterility: leaking bags
Published
April 10, 2024
Distribution
Nationwide

View recall →

FDA Recall OngoingHistorical recordClass II

Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.

by IntegraDose Compounding Services LLC

Reason
Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.
Published
February 21, 2024
Distribution
MN

View recall →

FDA Recall OngoingHistorical recordClass II

Vasopressin 2 Unit/2 mL in 0.9% Sodium Chloride, 2 mL per syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-0190-1

by IntegraDose Compounding Services LLC

Reason
Subpotent Drug
Published
January 31, 2024
Distribution
MN only

View recall →

FDA Recall TerminatedTerminated: October 2, 2022Historical recordClass II

ceFAZolin 3 G in 0.9% Sodium Chloride, 115 mL Bag for Injection, Sterile Product, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC: 71139-7153-1

by IntegraDose Compounding Services LLC

Reason
Lack of sterility assurance.
Published
October 6, 2021
Distribution
Multiple states

View recall →

FDA Recall TerminatedTerminated: October 2, 2022Historical recordClass II

ceFAZolin, 2 G/20 mL in Sterile Water, 20 mL Sterile Syringe for Injection, IntegraDose Compounding Services, LLC, 719 Kasota Ave SE, Minneapolis, MN. NDC 71139-7087-1

by IntegraDose Compounding Services LLC

Reason
Lack of sterility assurance.
Published
October 6, 2021
Distribution
Multiple states

View recall →

Showing 1–8 of 8 results

Some FDA recall records on this page come from FDA's Enforcement Report database. Not every Enforcement Report record has a separate FDA.gov recall-announcement page.

This page lists recalls that name IntegraDose Compounding Services LLC as the recalling firm in the official source notice. It is not a safety rating, ranking, or statement that the company acted negligently. Read the full medical disclaimer.